TL1A as a therapeutic target in inflammatory bowel disease

被引：7
|
作者：
Kokkotis, Georgios [1 ]
Bamias, Giorgos [1 ]
机构：
[1] Natl & Kapodistrian Univ Athens, Sotiria Hosp, Dept Internal Med 3, GI Unit, Athens, Greece
来源：
EXPERT REVIEW OF CLINICAL IMMUNOLOGY | 2022年 / 18卷 / 06期
关键词：
IBD; intervention; mucosal immunity; TL1A; TNFSF15; TNF-LIKE LIGAND; CYTOKINE; LYMPHOCYTES; EXPRESSION; CELL; 1A;
D O I：
10.1080/1744666X.2022.2074401
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：551 / 555
页数：5
相关论文
共 50 条
  • [1] TL1A: A New Potential Target in the Treatment of Inflammatory Bowel Disease
    Furfaro, Federica
    Alfarone, Ludovico
    Gilardi, Daniela
    Correale, Carmen
    Allocca, Mariangela
    Fiorino, Gionata
    Argollo, Marjorie
    Zilli, Alessandra
    Zacharopoulou, Eirini
    Loy, Laura
    Roda, Giulia
    Danese, Silvio
    [J]. CURRENT DRUG TARGETS, 2021, 22 (07) : 760 - 769
  • [2] TL1A inhibition for inflammatory bowel disease treatment: From inflammation to fibrosis
    Solitano, Virginia
    Jairath, Vipul
    Ungaro, Federica
    Peyrin-Biroulet, Laurent
    Danese, Silvio
    [J]. MED, 2024, 5 (05): : 386 - 400
  • [3] Expression, localization, and functional activity of TL1A, a novel Th1-polarizing cytokine in inflammatory bowel disease
    Bamias, G
    Martin, C
    Marini, M
    Hoang, S
    Mishina, M
    Ross, WG
    Sachedina, MA
    Friel, CM
    Mize, J
    Bickston, SJ
    Pizarro, TT
    Wei, P
    Cominelli, F
    [J]. JOURNAL OF IMMUNOLOGY, 2003, 171 (09): : 4868 - 4874
  • [4] Reduced monocyte and macrophage TNFSF15/TL1A expression is associated with susceptibility to inflammatory bowel disease
    Richard, Arianne C.
    Peters, James E.
    Savinykh, Natalia
    Lee, James C.
    Hawley, Eric T.
    Meylan, Francoise
    Siegel, Richard M.
    Lyons, Paul A.
    Smith, Kenneth G. C.
    [J]. PLOS GENETICS, 2018, 14 (09):
  • [5] ESSENTIAL ROLE OF TNFRSF25/TL1A IN THE DEVELOPMENT OF ALLERGIC LUNG INFLAMMATION AND INFLAMMATORY BOWEL DISEASE
    Fang, Lei
    Adkins, Becky
    Deyev, Vadim
    Podack, Eckhard R.
    [J]. ADVANCES IN TNF FAMILY RESEARCH, 2011, 691 : 771 - 771
  • [6] TL1A in the inflammatory network in autoimmune diseases
    Jagadeesh Bayry
    [J]. Nature Reviews Rheumatology, 2010, 6 : 67 - 68
  • [7] TL1A as a Potential Local Inducer of IL17A Expression in Colon Mucosa of Inflammatory Bowel Disease Patients
    Slebioda, T. J.
    Bojarska-Junak, A.
    Stanislawowski, M.
    Cyman, M.
    Wierzbicki, P. M.
    Rolinski, J.
    Celinski, K.
    Kmiec, Z.
    [J]. SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2015, 82 (04) : 352 - 360
  • [8] Intestinal microflora as a therapeutic target in inflammatory bowel disease
    Mitsuyama, K
    Toyonaga, A
    Sata, M
    [J]. JOURNAL OF GASTROENTEROLOGY, 2002, 37 (Suppl 14) : 73 - 77
  • [9] Intestinal microflora as a therapeutic target in inflammatory bowel disease
    Keiichi Mitsuyama
    Atsushi Toyonaga
    Michio Sata
    [J]. Journal of Gastroenterology, 2002, 37 : 73 - 77
  • [10] Microecology as a target for therapeutic intervention in inflammatory bowel disease
    Guarner, F
    [J]. IDRUGS, 2003, 6 (09) : 868 - 873
12345